{"id":"carbocisteine","rwe":[{"pmid":"41885983","year":"2026","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis. Reply.","finding":"","journal":"The New England journal of medicine","studyType":"Clinical Study"},{"pmid":"41885982","year":"2026","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis.","finding":"","journal":"The New England journal of medicine","studyType":"Clinical Study"},{"pmid":"41885981","year":"2026","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis.","finding":"","journal":"The New England journal of medicine","studyType":"Clinical Study"},{"pmid":"41885980","year":"2026","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis.","finding":"","journal":"The New England journal of medicine","studyType":"Clinical Study"},{"pmid":"41770503","year":"2026","title":"Ulcerative colitis, pathophysiological mechanisms and drug repurposing: a new therapeutic dawn-narrative review.","finding":"","journal":"Inflammopharmacology","studyType":"Clinical Study"}],"tags":[{"label":"carbocisteine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R05CB03","category":"atc"},{"label":"Active","category":"status"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Anti-Infective Agents, Local","category":"pharmacology"},{"label":"Expectorants","category":"pharmacology"},{"label":"Respiratory System Agents","category":"pharmacology"}],"phase":"unknown","safety":{"safetySignals":[{"llr":219.297,"date":"","count":186,"signal":"Interstitial lung disease","source":"DrugCentral FAERS","actionTaken":"Reported 186 times (LLR=219)"},{"llr":189.274,"date":"","count":141,"signal":"Hepatic function abnormal","source":"DrugCentral FAERS","actionTaken":"Reported 141 times (LLR=189)"},{"llr":179.644,"date":"","count":58,"signal":"Pulmonary pain","source":"DrugCentral FAERS","actionTaken":"Reported 58 times (LLR=180)"},{"llr":136.283,"date":"","count":60,"signal":"Drug ineffective","source":"DrugCentral FAERS","actionTaken":"Reported 60 times (LLR=136)"},{"llr":127.957,"date":"","count":387,"signal":"Pneumonia","source":"DrugCentral FAERS","actionTaken":"Reported 387 times (LLR=128)"},{"llr":124.885,"date":"","count":108,"signal":"Pneumonia aspiration","source":"DrugCentral FAERS","actionTaken":"Reported 108 times (LLR=125)"},{"llr":115.303,"date":"","count":40,"signal":"Upper respiratory tract inflammation","source":"DrugCentral FAERS","actionTaken":"Reported 40 times (LLR=115)"},{"llr":113.85,"date":"","count":150,"signal":"Lower respiratory tract infection","source":"DrugCentral FAERS","actionTaken":"Reported 150 times (LLR=114)"},{"llr":90.852,"date":"","count":64,"signal":"Fatigue","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=91)"},{"llr":90.589,"date":"","count":55,"signal":"Pneumonia bacterial","source":"DrugCentral FAERS","actionTaken":"Reported 55 times (LLR=91)"},{"llr":90.279,"date":"","count":74,"signal":"Drug eruption","source":"DrugCentral FAERS","actionTaken":"Reported 74 times (LLR=90)"},{"llr":87.925,"date":"","count":23,"signal":"Radiation inflammation","source":"DrugCentral FAERS","actionTaken":"Reported 23 times (LLR=88)"},{"llr":73.787,"date":"","count":18,"signal":"Amyloid arthropathy","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=74)"},{"llr":72.343,"date":"","count":130,"signal":"Hyponatraemia","source":"DrugCentral FAERS","actionTaken":"Reported 130 times (LLR=72)"},{"llr":63.996,"date":"","count":137,"signal":"Platelet count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 137 times (LLR=64)"}],"commonSideEffects":[{"effect":"Interstitial lung disease","drugRate":"LLR 219","severity":"common"},{"effect":"Hepatic function abnormal","drugRate":"LLR 189","severity":"common"},{"effect":"Pulmonary pain","drugRate":"LLR 180","severity":"common"},{"effect":"Pneumonia","drugRate":"LLR 128","severity":"common"},{"effect":"Upper respiratory tract inflammation","drugRate":"LLR 115","severity":"common"},{"effect":"Lower respiratory tract infection","drugRate":"LLR 114","severity":"common"},{"effect":"Fatigue","drugRate":"LLR 91","severity":"common"},{"effect":"Drug eruption","drugRate":"LLR 90","severity":"common"},{"effect":"Radiation inflammation","drugRate":"LLR 88","severity":"common"},{"effect":"Amyloid arthropathy","drugRate":"LLR 74","severity":"common"},{"effect":"Hyponatraemia","drugRate":"LLR 72","severity":"common"},{"effect":"Platelet count decreased","drugRate":"LLR 64","severity":"common"}],"contraindications":["Gastrointestinal hemorrhage","Gastrointestinal ulcer"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"pectdrill","offLabel":[],"synonyms":["carbocisteine","bronchokod","carbocit","carbocysteine","chilvax","L-(Carboxymethyl)cysteine","lisil","lisomucil","loviscol","muciclar","mucocis","mucodyne","mucofan","mucolase","mucolex","mucopront","mucosol","mucotab","mukinyl","PectDrill","pectox","pulmoclase","reomucil","rhinathiol","rhinatiol","thiodril","transbronchin","carbocisteine sodium"],"timeline":[],"brandName":"Pectdrill","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"carbocisteine","explanation":"Imagine your lungs are clogged with sticky mucus. Carbocisteine helps to break down this mucus, making it easier to cough up and breathe more easily. This can be especially helpful for people with conditions like chronic bronchitis or cystic fibrosis.","oneSentence":"Carbocisteine works by breaking down and clearing mucus from the lungs, making it easier to breathe.","technicalDetail":"Carbocisteine is a mucolytic agent that works by inhibiting the disulfide bonds in mucin, the main component of mucus, thereby reducing its viscosity and making it easier to clear from the airways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4160","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=carbocisteine","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=carbocisteine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:10:17.344172","biosimilars":[],"competitors":[{"drugName":"acetylcysteine","drugSlug":"acetylcysteine","fdaApproval":"1963-09-14","patentExpiry":"May 8, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"mesna","drugSlug":"mesna","fdaApproval":"1988-12-30","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"dornase alfa","drugSlug":"dornase-alfa","fdaApproval":"1993-12-30","relationship":"same-class"},{"drugName":"mannitol","drugSlug":"mannitol","fdaApproval":"1964-06-08","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"carbocisteine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"acetylcysteine","brandName":"acetylcysteine","genericName":"acetylcysteine","approvalYear":"1963","relationship":"same-class"},{"drugId":"mesna","brandName":"mesna","genericName":"mesna","approvalYear":"1988","relationship":"same-class"},{"drugId":"dornase-alfa","brandName":"dornase alfa","genericName":"dornase alfa","approvalYear":"1993","relationship":"same-class"},{"drugId":"mannitol","brandName":"mannitol","genericName":"mannitol","approvalYear":"1964","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04140214","phase":"PHASE3","title":"Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR)","status":"COMPLETED","sponsor":"Belfast Health and Social Care Trust","startDate":"2018-06-27","conditions":["Bronchiectasis"],"enrollment":288,"completionDate":"2024-12-18"},{"nctId":"NCT06863376","phase":"PHASE2","title":"Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-03-01","conditions":["Non-Alcoholic Fatty Liver Disease"],"enrollment":46,"completionDate":"2026-04-20"},{"nctId":"NCT02858193","phase":"PHASE1","title":"Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2016-07-04","conditions":["Bronchitis"],"enrollment":30,"completionDate":"2016-10-10"},{"nctId":"NCT05378022","phase":"NA","title":"Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2020-12-21","conditions":["Acute Respiratory Tract Infections"],"enrollment":70,"completionDate":"2022-04-22"},{"nctId":"NCT03177889","phase":"NA","title":"Lung Dispersing, Turbid Descending and Gut Clearing Decoction for Bronchiectasis","status":"UNKNOWN","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2021-12-31","conditions":["Bronchiectasis Adult","Traditional Chinese Medicine","Quality of Life","Exacerbation"],"enrollment":80,"completionDate":"2023-12-31"},{"nctId":"NCT02765295","phase":"NA","title":"Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study","status":"UNKNOWN","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2016-06-01","conditions":["Bronchiectasis","Acute Exacerbation of Bronchiectasis","Oxidative Stress"],"enrollment":120,"completionDate":"2021-12"},{"nctId":"NCT01968434","phase":"PHASE4","title":"Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.","status":"COMPLETED","sponsor":"Clalit Health Services","startDate":"2013-12","conditions":["Cough","Upper Respiratory Tract Infection"],"enrollment":150,"completionDate":"2014-04"},{"nctId":"NCT02015598","phase":"NA","title":"Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome","status":"COMPLETED","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2013-12","conditions":["Obstructive Sleep Apnoea"],"enrollment":40,"completionDate":"2014-05"},{"nctId":"NCT01693471","phase":"","title":"Survey on the Effect of Health Related Quality of Life (QOL) Associated With Compliance of Carbocisteine in Asthma Patients","status":"COMPLETED","sponsor":"Kyorin Pharmaceutical Co.,Ltd","startDate":"2012-09","conditions":["Asthma"],"enrollment":179,"completionDate":"2013-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"NUI":"N0000170286","MMSL":"26469","NDDF":"003677","UNII":"740J2QX53R","CHEBI":"CHEBI:16163","INN_ID":"2884","RXNORM":"2023","UMLSCUI":"C0006992","ChEMBL_ID":"CHEMBL396416","KEGG_DRUG":"D06393","DRUGBANK_ID":"DB04339","PDB_CHEM_ID":"CAY","PUBCHEM_CID":"193653","SNOMEDCT_US":"395842001","MESH_DESCRIPTOR_UI":"D002233"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":117,"therapeuticAreas":["Respiratory"],"atcClassification":{"source":"DrugCentral","atcCode":"R05CB03","allCodes":["R05CB03"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Feb 5","pmid":"41885983","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis. Reply.","journal":"The New England journal of medicine"},{"date":"2026 Feb 5","pmid":"41885982","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis.","journal":"The New England journal of medicine"},{"date":"2026 Feb 5","pmid":"41885981","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis.","journal":"The New England journal of medicine"},{"date":"2026 Feb 5","pmid":"41885980","title":"Hypertonic Saline or Carbocisteine in Bronchiectasis.","journal":"The New England journal of medicine"},{"date":"2026 Mar 2","pmid":"41770503","title":"Ulcerative colitis, pathophysiological mechanisms and drug repurposing: a new therapeutic dawn-narrative review.","journal":"Inflammopharmacology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Carbocisteine is a small molecule that acts as a mucolytic, reducing the viscosity of sputum. It is used to relieve symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by facilitating easier sputum expulsion.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}